[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100637828":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":23,"locations":29,"responsibleParty":50,"collaborators":10,"id":53,"slug":54,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":57,"acronym":58,"eligibilityCriteria":59,"healthyVolunteers":55,"sex":60,"minAge":61,"maxAge":10,"enrollmentInfo":62,"targetDuration":10,"studyType":65,"phases":10,"briefSummary":66,"conditions":67,"keywords":72,"overallStatus":32,"whyStopped":10,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"Mayo Clinic","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Cardiac Sarcoidosis Patients",null,"Patients with a clinical suspicion or a previously confirmed diagnosis of cardiac sarcoidosis.",[13],"Other: Exosome Analysis",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"Exosome Analysis","Blood Samples will undergo exosome profiling using mass spectrometry and\u002For other discovery-based approaches",[9],[20],{"name":21,"affiliation":5,"role":22},"Andrew Rosenbaum, MD","PRINCIPAL_INVESTIGATOR",[24],{"name":25,"role":26,"phone":27,"phoneExt":10,"email":28},"Anna Pick","CONTACT","507-255-0630","pick.anna@mayo.edu",[30],{"facility":31,"status":32,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"Mayo Clinic in Rochester","RECRUITING","Rochester","Minnesota","55905","United States","US",{"type":39,"coordinates":40},"Point",[41,42],-92.4699,44.02163,{"lat":42,"lon":41},[45,46,49],{"name":25,"role":26,"phone":27,"phoneExt":10,"email":28},{"name":21,"role":26,"phone":47,"phoneExt":10,"email":48},"(507) 284-0783","Rosenbaum.Andrew@mayo.edu",{"name":21,"role":22,"phone":10,"phoneExt":10,"email":10},{"type":22,"investigatorFullName":51,"investigatorTitle":52,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Andrew N Rosenbaum","Principal Investigator","100637828","exosome-based-omic-signatures-of-disease-activity-in-cardiac-sarcoidosis-exodacs-100637828",false,"NCT07604220","Exosome-based Omic Signatures of Disease Activity in Cardiac Sarcoidosis (EXODACS)","EXODACS","Inclusion Criteria\n\n* Adults ≥18 years.\n* Patients referred to the Cardiac Sarcoid Clinic with a clinical suspicion or a previously confirmed diagnosis of cardiac sarcoidosis.\n* Undergoing FDG-PET as part of standard care.\n* Ability to provide informed consent.\n\nExclusion Criteria\n\n• Inability to provide informed consent.","ALL","18 Years",{"count":63,"type":64},115,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to develop a prospective cohort of patients with and without cardiac sarcoidosis as well as active and inactive disease to develop a prospective biobank from which exosome analysis of peripheral blood will derive unique biomarkers of disease activity in cardiac sarcoidosis.",[68,69,70,71],"Cardiac Sarcoidosis","Sarcoidosis of the Heart","Sarcoidosis With Myocarditis","Sarcoidosis, Cardiac",[73,74,75,76],"cardiac sarcoidosis","FDG-PET","disease activity","proteomics","2026-08-13",{"date":79,"type":80},"2026-08-17","ACTUAL",{"date":82,"type":80},"2026-07-13",{"date":84,"type":64},"2028-07",{"name":5,"class":6},1]